NFKB1 and colorectal carcinoma: Moreover, NF-κB inhibition may reverse cisplatin resistance in gastric cancer cells [81] and restore chemosensitivity including oxaliplatin and vincristine in CRC cells by preventing NRF2/MRP2 axis [83] that might enhance multidrug resistance in various tumors.